Alba 
 Sitemapcontactlogin 
HomePic.jpg
Clinical Trial Information Links


Click here to see if you qualify for this clinical research study




For more information about participating in a clinical trial, contact:

E-mail: info@albatherapeutics.com




Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland.
NEW PUBLICATIONS
Larazotide Acetate Regulates Epithelial Tight Junctions in Vitro and in Vivo

Reference: Gopalakrishnan S, Durai M, Kitchens K, Tamiz AP, Somerville R, Ginski M, Paterson BM, Murray JA, Verdu EF, Alkan SS, Pandey NB. Larazotide Acetate Regulates Epithelial Tight Junctions in Vitro and in Vivo. Peptides. 2012 Feb 27.

View here >>

 


Larazotide Acetate Promotes Tight Junction Assembly in Epithelial Cells

Reference: Gopalakrishnan S, Tripathi A, Tamiz AP, Alkan SS, Pandey NB. Larazotide Acetate Promotes Tight Junction Assembly in Epithelial Cells. Peptide. 2012 May.

View here >>

Press Releases: 2012
                          2011
Copyright 2011 Alba Therapeutics Corporation. All Rights Reserved. Design: R2i
canakkalecanakkalegelibolufree online games